Imagion Biosystems Ltd has released a press release.
FY2018 Appendix 4E and Preliminary Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Imagion Biosystems Ltd. on 6ix
Story so far
Earlier from Imagion Biosystems
- Imagion Biosystems Raises $4.3M Via Rights Issue
- Despatch of Rights Issue Offer Documents
- Rights Issue Offer Document
- Market Announcement - Reinstatement to official quotation
- Pro-Rata Non-Renounceable Rights Issue
Later from Imagion Biosystems
- IBX receives US patent related to treatment of disease
- IBX receives order related to cancer treatment
- Imagion Biosystems receives R&D Advanced Overseas Finding
- Imagion Biosystems successfully completes toxicology study
- FDA Breakthrough Device Designation
Follow Imagion Biosystems into a list and get an email when it puts out news.
Follow Imagion Biosystems